Literature DB >> 33716385

Disentangling Moral Hazard and Adverse Selection in Private Health Insurance.

David Powell1, Dana Goldman2.   

Abstract

Moral hazard and adverse selection create inefficiencies in private health insurance markets and understanding the relative importance of each factor is critical for addressing these inefficiencies. We use claims data from a large firm which changed health insurance plan options to isolate moral hazard from plan selection, estimating a discrete choice model to predict household plan preferences and attrition. Variation in plan preferences identifies the differential causal impact of each health insurance plan on the entire distribution of medical expenditures. Our estimates imply that 53% of the additional medical spending observed in the most generous plan in our data relative to the least generous is due to adverse selection. We find that quantifying adverse selection by using prior medical expenditures overstates the true magnitude of selection due to mean reversion. We also statistically reject that individual health care consumption responds solely to the end-of-the-year marginal price.

Entities:  

Keywords:  Adverse Selection; Attrition Bias; C21; C23; Health Insurance; I11; I13; Moral Hazard; Nonadditive Selection Model; Price Elasticity; Quantile Treatment Effects

Year:  2020        PMID: 33716385      PMCID: PMC7945045          DOI: 10.1016/j.jeconom.2020.07.030

Source DB:  PubMed          Journal:  J Econom        ISSN: 0304-4076            Impact factor:   2.388


  18 in total

1.  Asymmetric information in health insurance: evidence from the National Medical Expenditure Survey.

Authors:  J H Cardon; I Hendel
Journal:  Rand J Econ       Date:  2001

2.  Taxation, health insurance, and market failure in the medical economy.

Authors:  M V Pauly
Journal:  J Econ Lit       Date:  1986

3.  The demand for episodes of treatment in the Health Insurance Experiment.

Authors:  E B Keeler; J E Rolph
Journal:  J Health Econ       Date:  1988-12       Impact factor: 3.883

4.  Attrition in the RAND Health Insurance Experiment: a response to Nyman.

Authors:  Joseph P Newhouse; Robert H Brook; Naihua Duan; Emmett B Keeler; Arleen Leibowitz; Willard G Manning; M Susan Marquis; Carl N Morris; Charles E Phelps; John E Rolph
Journal:  J Health Polit Policy Law       Date:  2008-04       Impact factor: 2.265

5.  How product standardization affects choice: Evidence from the Massachusetts Health Insurance Exchange.

Authors:  Keith M Marzilli Ericson; Amanda Starc
Journal:  J Health Econ       Date:  2016-09-21       Impact factor: 3.883

6.  The anticipatory effects of Medicare Part D on drug utilization.

Authors:  Abby Alpert
Journal:  J Health Econ       Date:  2016-06-22       Impact factor: 3.883

7.  Adverse Selection and Inertia in Health Insurance Markets: When Nudging Hurts.

Authors:  Benjamin R Handel
Journal:  Am Econ Rev       Date:  2013-12

8.  The value of health insurance: the access motive.

Authors:  J A Nyman
Journal:  J Health Econ       Date:  1999-04       Impact factor: 3.883

9.  Patient cost-sharing and healthcare spending growth.

Authors:  Katherine Baicker; Dana Goldman
Journal:  J Econ Perspect       Date:  2011

10.  Selection on Moral Hazard in Health Insurance.

Authors:  Liran Einav; Amy Finkelstein; Stephen Ryan; Paul Schrimpf; Mark R Cullen
Journal:  Am Econ Rev       Date:  2013-02
View more
  1 in total

1.  How Public Trust in Health Care Can Shape Patient Overconsumption in Health Systems? The Missing Links.

Authors:  Katarzyna Krot; Iga Rudawska
Journal:  Int J Environ Res Public Health       Date:  2021-04-07       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.